Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased With Obesity in Patients with Heart Failure.

Lewis LK, Raudsepp SD, Prickett TCR, Yandle TG, Doughty RN, Frampton CM, Pemberton CJ, Richards AM.

Clin Chem. 2019 May 15. pii: clinchem.2019.302547. doi: 10.1373/clinchem.2019.302547. [Epub ahead of print]

PMID:
31092393
2.

Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes.

Marks ECA, Wilkinson TM, Frampton CM, Skelton L, Pilbrow AP, Yandle TG, Pemberton CJ, Doughty RN, Whalley GA, Ellis CJ, Troughton RW, Owen MC, Pattinson NR, Cameron VA, Richards AM, Gieseg SP, Palmer BR.

BMC Cardiovasc Disord. 2018 Aug 15;18(1):169. doi: 10.1186/s12872-018-0894-1.

3.

Development of a BNP1-32 Immunoassay That Does Not Cross-React with proBNP.

Lewis LK, Raudsepp SD, Yandle TG, Prickett TC, Richards AM.

Clin Chem. 2017 Jun;63(6):1110-1117. doi: 10.1373/clinchem.2016.269712. Epub 2017 Apr 20.

4.

High-Sensitivity Sandwich ELISA for Plasma NT-proUcn2: Plasma Concentrations and Relationship to Mortality in Heart Failure.

Liew OW, Yandle TG, Chong JP, Ng YX, Frampton CM, Ng TP, Lam CS, Richards AM.

Clin Chem. 2016 Jun;62(6):856-65. doi: 10.1373/clinchem.2015.252932. Epub 2016 Apr 28.

5.

(Pro)renin Receptor Blockade Ameliorates Cardiac Injury and Remodeling and Improves Function After Myocardial Infarction.

Ellmers LJ, Rademaker MT, Charles CJ, Yandle TG, Richards AM.

J Card Fail. 2016 Jan;22(1):64-72. doi: 10.1016/j.cardfail.2015.08.341. Epub 2015 Sep 8.

PMID:
26362519
6.

B-type Natriuretic Peptide circulating forms: Analytical and bioactivity issues.

Yandle TG, Richards AM.

Clin Chim Acta. 2015 Aug 25;448:195-205. doi: 10.1016/j.cca.2015.07.004. Epub 2015 Jul 6. Review.

PMID:
26160054
7.

Circulating miR-323-3p and miR-652: candidate markers for the presence and progression of acute coronary syndromes.

Pilbrow AP, Cordeddu L, Cameron VA, Frampton CM, Troughton RW, Doughty RN, Whalley GA, Ellis CJ, Yandle TG, Richards AM, Foo RS.

Int J Cardiol. 2014 Sep 20;176(2):375-85. doi: 10.1016/j.ijcard.2014.07.068. Epub 2014 Jul 22.

PMID:
25124998
8.

Endogenous ouabain is not ouabain.

Lewis LK, Yandle TG, Hilton PJ, Jensen BP, Begg EJ, Nicholls MG.

Hypertension. 2014 Oct;64(4):680-3. doi: 10.1161/HYPERTENSIONAHA.114.03919. Epub 2014 Jul 7. Review. No abstract available.

PMID:
25001271
9.

Genetic polymorphism rs6922269 in the MTHFD1L gene is associated with survival and baseline active vitamin B12 levels in post-acute coronary syndromes patients.

Palmer BR, Slow S, Ellis KL, Pilbrow AP, Skelton L, Frampton CM, Palmer SC, Troughton RW, Yandle TG, Doughty RN, Whalley GA, Lever M, George PM, Chambers ST, Ellis C, Richards AM, Cameron VA.

PLoS One. 2014 Mar 11;9(3):e89029. doi: 10.1371/journal.pone.0089029. eCollection 2014.

10.

B-type natriuretic peptide forms within the heart, coronary sinus, and peripheral circulation in humans: evidence for degradation before secretion.

Mahagamasekera PG, Ruygrok PN, Palmer SC, Richards AM, Ansell GS, Nicholls MG, Pemberton CJ, Lewis LK, Yandle TG.

Clin Chem. 2014 Mar;60(3):549-58. doi: 10.1373/clinchem.2013.210435. Epub 2014 Jan 10.

11.

Increased plasma norepinephrine levels in previously pre-eclamptic women.

Lampinen KH, Rönnback M, Groop PH, Nicholls MG, Yandle TG, Kaaja RJ.

J Hum Hypertens. 2014 Apr;28(4):269-73. doi: 10.1038/jhh.2013.84. Epub 2013 Sep 19.

PMID:
24048293
12.

ANP and BNP responses to dehydration in the one-humped camel and effects of blocking the renin-angiotensin system.

Adem A, Al Haj M, Benedict S, Yasin J, Nagelkerke N, Nyberg F, Yandle TG, Frampton CM, Lewis LK, Nicholls MG, Kazzam E.

PLoS One. 2013;8(3):e57806. doi: 10.1371/journal.pone.0057806. Epub 2013 Mar 13.

13.

Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA.

Lewis LK, Raudsepp SD, Yandle TG, Frampton CM, Palmer SC, Troughton RW, Richards AM.

Clin Biochem. 2013 Mar;46(4-5):388-90. doi: 10.1016/j.clinbiochem.2012.11.022. Epub 2012 Dec 4.

PMID:
23219736
14.

Hemodynamic, hormonal, and renal effects of (pro)renin receptor blockade in experimental heart failure.

Rademaker MT, Yandle TG, Ellmers LJ, Charles CJ, Nicholls MG, Richards AM.

Circ Heart Fail. 2012 Sep 1;5(5):645-52. Epub 2012 Jul 12.

PMID:
22798523
15.

Genetic variation in the renin-angiotensin-aldosterone system is associated with cardiovascular risk factors and early mortality in established coronary heart disease.

Ellis KL, Palmer BR, Frampton CM, Troughton RW, Doughty RN, Whalley GA, Ellis CJ, Pilbrow AP, Skelton L, Yandle TG, Richards AM, Cameron VA.

J Hum Hypertens. 2013 Apr;27(4):237-44. doi: 10.1038/jhh.2012.24. Epub 2012 Jun 28.

PMID:
22739771
16.

Responses to dehydration in the one-humped camel and effects of blocking the renin-angiotensin system.

Ali MA, Adem A, Chandranath IS, Benedict S, Pathan JY, Nagelkerke N, Nyberg F, Lewis LK, Yandle TG, Nicholls GM, Frampton CM, Kazzam E.

PLoS One. 2012;7(5):e37299. doi: 10.1371/journal.pone.0037299. Epub 2012 May 18.

17.

Association between endothelin type A receptor haplotypes and mortality in coronary heart disease.

Ellis KL, Pilbrow AP, Potter HC, Frampton CM, Doughty RN, Whalley GA, Ellis CJ, Palmer BR, Skelton L, Yandle TG, Troughton RW, Richards AM, A Cameron V.

Per Med. 2012 May;9(3):341-349. doi: 10.2217/pme.12.10.

PMID:
29758796
18.

Comparative pharmacokinetics and pharmacodynamics of urocortins 1, 2 and 3 in healthy sheep.

Patel K, Rademaker MT, Kirkpatrick CM, Charles CJ, Fisher S, Yandle TG, Richards AM.

Br J Pharmacol. 2012 Jul;166(6):1916-25. doi: 10.1111/j.1476-5381.2012.01904.x.

19.

First identification of circulating prepro-A-type natriuretic peptide (preproANP) signal peptide fragments in humans: initial assessment as cardiovascular biomarkers.

Pemberton CJ, Siriwardena M, Kleffmann T, Ruygrok P, Palmer SC, Yandle TG, Richards AM.

Clin Chem. 2012 Apr;58(4):757-67. doi: 10.1373/clinchem.2011.176990. Epub 2012 Jan 30.

20.

Pharmacodynamic responses of plasma and tissue C-type natriuretic peptide to GH: correlation with linear growth in GH-deficient rats.

Prickett TC, Bothwell JC, Yandle TG, Richards AM, Espiner EA.

J Endocrinol. 2012 Feb;212(2):217-25. doi: 10.1530/JOE-11-0387. Epub 2011 Nov 15.

PMID:
22087017
21.

Interference by o-phenanthroline in the radioimmunoassay of angiotensin II in small volume blood samples.

Braithwaite JE, Yandle TG, Nicholls MG, Lewis LK.

Clin Biochem. 2012 Jan;45(1-2):168-70. doi: 10.1016/j.clinbiochem.2011.10.008. Epub 2011 Oct 22.

PMID:
22040809
22.

KCNE5 polymorphism rs697829 is associated with QT interval and survival in acute coronary syndromes patients.

Palmer BR, Frampton CM, Skelton L, Yandle TG, Doughty RN, Whalley GA, Ellis CJ, Troughton RW, Richards AM, Cameron VA.

J Cardiovasc Electrophysiol. 2012 Mar;23(3):319-24. doi: 10.1111/j.1540-8167.2011.02192.x. Epub 2011 Oct 10.

PMID:
21985337
23.

Genomic risk variants at 1p13.3, 1q41, and 3q22.3 are associated with subsequent cardiovascular outcomes in healthy controls and in established coronary artery disease.

Ellis KL, Frampton CM, Pilbrow AP, Troughton RW, Doughty RN, Whalley GA, Ellis CJ, Skelton L, Thomson J, Yandle TG, Richards AM, Cameron VA.

Circ Cardiovasc Genet. 2011 Dec;4(6):636-46. doi: 10.1161/CIRCGENETICS.111.960336. Epub 2011 Oct 7.

PMID:
21984477
24.

Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes.

Ellis KL, Newton-Cheh C, Wang TJ, Frampton CM, Doughty RN, Whalley GA, Ellis CJ, Skelton L, Davis N, Yandle TG, Troughton RW, Richards AM, Cameron VA.

J Mol Cell Cardiol. 2011 Apr;50(4):695-701. doi: 10.1016/j.yjmcc.2011.01.010. Epub 2011 Jan 27.

PMID:
21276798
25.

Central and peripheral forms of C-type natriuretic peptide (CNP): evidence for differential regulation in plasma and cerebrospinal fluid.

Schouten BJ, Prickett TC, Hooper AA, Hooper GJ, Yandle TG, Richards AM, Espiner EA.

Peptides. 2011 Apr;32(4):797-804. doi: 10.1016/j.peptides.2011.01.013. Epub 2011 Jan 22.

PMID:
21262296
26.

B-type natriuretic peptides: looking to the future.

Troughton RW, Lewis LK, Yandle TG, Pemberton CJ, Nicholls MG.

Ann Med. 2011 May;43(3):188-97. doi: 10.3109/07853890.2010.526630. Epub 2010 Oct 21. Review.

PMID:
20961274
27.

Clinical significance of endogenous vasoactive neurohormones in chronic systolic heart failure.

Tang WH, Shrestha K, Martin MG, Borowski AG, Jasper S, Yandle TG, Richards AM, Klein AL, Troughton RW.

J Card Fail. 2010 Aug;16(8):635-40. doi: 10.1016/j.cardfail.2010.03.011. Epub 2010 May 8.

PMID:
20670842
28.

Plasma corin levels provide minimal prognostic utility incremental to natriuretic peptides in chronic systolic heart failure.

Shrestha K, Troughton RW, Borowski AG, Yandle TG, Richards AM, Klein AL, Tang WH.

J Card Fail. 2010 Aug;16(8):621-7. doi: 10.1016/j.cardfail.2010.03.010. Epub 2010 May 4.

PMID:
20670840
29.

B-type natriuretic peptide signal peptide circulates in human blood: evaluation as a potential biomarker of cardiac ischemia.

Siriwardena M, Kleffmann T, Ruygrok P, Cameron VA, Yandle TG, Nicholls MG, Richards AM, Pemberton CJ.

Circulation. 2010 Jul 20;122(3):255-64. doi: 10.1161/CIRCULATIONAHA.109.909937. Epub 2010 Jul 6.

PMID:
20606123
30.

A common variant at chromosome 9P21.3 is associated with age of onset of coronary disease but not subsequent mortality.

Ellis KL, Pilbrow AP, Frampton CM, Doughty RN, Whalley GA, Ellis CJ, Palmer BR, Skelton L, Yandle TG, Palmer SC, Troughton RW, Richards AM, Cameron VA.

Circ Cardiovasc Genet. 2010 Jun;3(3):286-93. doi: 10.1161/CIRCGENETICS.109.917443. Epub 2010 Apr 17.

PMID:
20400779
31.

Improving risk stratification in heart failure: a role for new biomarkers?

Yandle TG, Troughton RW.

Eur J Heart Fail. 2010 Apr;12(4):315-8. doi: 10.1093/eurjhf/hfq030. No abstract available.

32.

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.

Lainchbury JG, Troughton RW, Strangman KM, Frampton CM, Pilbrow A, Yandle TG, Hamid AK, Nicholls MG, Richards AM.

J Am Coll Cardiol. 2009 Dec 29;55(1):53-60. doi: 10.1016/j.jacc.2009.02.095.

33.

Effect of nutrition on plasma C-type natriuretic peptide forms in adult sheep: evidence for enhanced C-type natriuretic peptide degradation during caloric restriction.

Prickett TC, Ryan JF, Wellby M, Barrell GK, Yandle TG, Richards AM, Espiner EA.

Metabolism. 2010 Jun;59(6):796-801. doi: 10.1016/j.metabol.2009.09.026. Epub 2009 Dec 16.

PMID:
20005543
34.

Plasma urocortin 1 in human heart failure.

Wright SP, Doughty RN, Frampton CM, Gamble GD, Yandle TG, Richards AM.

Circ Heart Fail. 2009 Sep;2(5):465-71. doi: 10.1161/CIRCHEARTFAILURE.108.840207. Epub 2009 Jul 8.

PMID:
19808377
35.

Urotensin II immunoreactivity in the human circulation: evidence for widespread tissue release.

Chen YH, Yandle TG, Richards AM, Palmer SC.

Clin Chem. 2009 Nov;55(11):2040-8. doi: 10.1373/clinchem.2009.131748. Epub 2009 Oct 1.

36.

Skeletal contributions to plasma CNP forms: evidence from regional sampling in growing lambs.

Prickett TC, Charles CJ, Yandle TG, Richards AM, Espiner EA.

Peptides. 2009 Dec;30(12):2343-7. doi: 10.1016/j.peptides.2009.07.023. Epub 2009 Aug 5.

PMID:
19664666
37.

CYP1A1 MSPI (T6235C) gene polymorphism is associated with mortality in acute coronary syndrome patients.

Jarvis MD, Palmer BR, Pilbrow AP, Ellis KL, Frampton CM, Skelton L, Doughty RN, Whalley GA, Ellis CJ, Yandle TG, Richards AM, Cameron VA.

Clin Exp Pharmacol Physiol. 2010 Feb;37(2):193-8. doi: 10.1111/j.1440-1681.2009.05261.x. Epub 2009 Jul 24.

PMID:
19650794
38.

Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function.

Palmer SC, Prickett TC, Espiner EA, Yandle TG, Richards AM.

Hypertension. 2009 Sep;54(3):612-8. doi: 10.1161/HYPERTENSIONAHA.109.135608. Epub 2009 Jul 20.

PMID:
19620509
39.

C-type natriuretic peptide forms in pregnancy: maternal plasma profiles during ovine gestation correlate with placental and fetal maturation.

McNeill BA, Barrell GK, Wellby M, Prickett TC, Yandle TG, Espiner EA.

Endocrinology. 2009 Oct;150(10):4777-83. doi: 10.1210/en.2009-0176. Epub 2009 Jul 16.

PMID:
19608649
40.

Regional clearance of amino-terminal pro-brain natriuretic peptide from human plasma.

Palmer SC, Yandle TG, Nicholls MG, Frampton CM, Richards AM.

Eur J Heart Fail. 2009 Sep;11(9):832-9. doi: 10.1093/eurjhf/hfp099. Epub 2009 Jul 15.

41.

The common G-866A polymorphism of the UCP2 gene and survival in diabetic patients following myocardial infarction.

Palmer BR, Devereaux CL, Dhamrait SS, Mocatta TJ, Pilbrow AP, Frampton CM, Skelton L, Yandle TG, Winterbourn CC, Richards AM, Montgomery HE, Cameron VA.

Cardiovasc Diabetol. 2009 Jun 15;8:31. doi: 10.1186/1475-2840-8-31.

42.

Renal and cardiac function for long-term (10 year) risk stratification after myocardial infarction.

Palmer SC, Yandle TG, Frampton CM, Troughton RW, Nicholls MG, Richards AM.

Eur Heart J. 2009 Jun;30(12):1486-94. doi: 10.1093/eurheartj/ehp132. Epub 2009 Apr 23.

PMID:
19389787
43.

Characterization of NT-proBNP in human urine.

Palmer SC, Endre ZH, Richards AM, Yandle TG.

Clin Chem. 2009 Jun;55(6):1126-34. doi: 10.1373/clinchem.2008.121673. Epub 2009 Apr 9.

44.

Intermedin (adrenomedullin-2): a potential protective role in human aortic endothelial cells.

Pearson LJ, Yandle TG, Nicholls MG, Evans JJ.

Cell Physiol Biochem. 2009;23(1-3):97-108. doi: 10.1159/000204098. Epub 2009 Feb 18.

45.

Ouabain, a circulating hormone secreted by the adrenals, is pivotal in cardiovascular disease. Fact or fantasy?

Nicholls MG, Lewis LK, Yandle TG, Lord G, McKinnon W, Hilton PJ.

J Hypertens. 2009 Jan;27(1):3-8. doi: 10.1097/HJH.0b013e32831101d1. Review.

PMID:
19050442
46.

Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort.

Palmer BR, Jarvis MD, Pilbrow AP, Ellis KL, Frampton CM, Skelton L, Yandle TG, Doughty RN, Whalley GA, Ellis CJ, Troughton RW, Richards AM, Cameron VA.

Am Heart J. 2008 Oct;156(4):752-8. doi: 10.1016/j.ahj.2008.06.013. Epub 2008 Aug 15.

PMID:
18926157
47.

Effect of sex steroids on plasma C-type natriuretic peptide forms: stimulation by oestradiol in lambs and adult sheep.

Prickett TC, Barrell GK, Wellby M, Yandle TG, Richards AM, Espiner EA.

J Endocrinol. 2008 Dec;199(3):481-7. doi: 10.1677/JOE-08-0267. Epub 2008 Sep 10.

PMID:
18784186
48.

Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction.

Palmer BR, Pilbrow AP, Frampton CM, Yandle TG, Skelton L, Nicholls MG, Richards AM.

Eur Heart J. 2008 Oct;29(20):2489-96. doi: 10.1093/eurheartj/ehn383. Epub 2008 Aug 28. Erratum in: Eur Heart J. 2008 Dec;29(24):3068.

PMID:
18757359
49.

Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarction.

Ellmers LJ, Scott NJ, Medicherla S, Pilbrow AP, Bridgman PG, Yandle TG, Richards AM, Protter AA, Cameron VA.

Endocrinology. 2008 Nov;149(11):5828-34. doi: 10.1210/en.2008-0165. Epub 2008 Jul 24.

PMID:
18653707
50.

Identification and biological activity of ovine and caprine calcitonin receptor-stimulating peptides 1 and 2.

Charles CJ, Katafuchi T, Yandle TG, Minamino N.

J Endocrinol. 2008 Aug;198(2):429-37. doi: 10.1677/JOE-08-0106. Epub 2008 May 15.

PMID:
18483201

Supplemental Content

Loading ...
Support Center